birth defect

Essential Reads: More Data on ADHD Medications and Pregnancy

Women with attention-deficit/hyperactivity disorder (ADHD) often discontinue psychostimulant  medications during pregnancy, especially if they have milder symptoms.  While this approach makes sense in terms of limiting unnecessary exposures in women with what appears to [...]

By |2021-01-19T10:49:57-04:00January 20th, 2021|ADHD Medications, Essential Reads, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Essential Reads: More Data on ADHD Medications and Pregnancy

Study Supporting the Reproductive Safety of Gabapentin During Pregnancy

Gabapentin (Neurontin) is now used in a wide variety of clinical settings — for the treatment of epilepsy, pain management, restless leg syndrome, anxiety, and sleep disturbance.  However, there is relatively little information regarding [...]

By |2020-11-17T15:58:03-04:00October 28th, 2020|Alternative & Complementary, Anti-Anxiety Medications, Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Study Supporting the Reproductive Safety of Gabapentin During Pregnancy

Clinical Update 2020: New Data on Duloxetine and Pregnancy

A few weeks ago, we published a clinical update for duloxetine (Cymbalta) and pregnancy, stating that there was little new to report since we last covered the topic in 2015.  It is somewhat amusing [...]

By |2020-08-13T14:28:20-04:00March 6th, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2020: New Data on Duloxetine and Pregnancy

Clinical Update 2020: Duloxetine and Pregnancy

Women face difficult choices when deciding whether or not to continue psychiatric medications during pregnancy.  For many years, we have typically recommended the older antidepressants, including the selective serotonin reuptake inhibitors or SSRIs such [...]

By |2020-08-10T12:44:33-04:00February 25th, 2020|Antidepressants, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Clinical Update 2020: Duloxetine and Pregnancy

Preliminary Data Raises Concerns About Modafinil Use in Pregnancy

Modafinil (brand name Provigil) is a wake-promoting agent which is used to treat sleepiness due to narcolepsy, shift work sleep disorder, or obstructive sleep apnea.  It is also used to in others settings, often [...]

By |2020-11-01T21:53:56-04:00January 31st, 2020|ADHD Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Preliminary Data Raises Concerns About Modafinil Use in Pregnancy

Interpreting New Data on the Use of Benzodiazepines During Pregnancy

Data regarding the reproductive safety of benzodiazepines has always been somewhat difficult to understand.  While earlier studies suggested an association between prenatal exposure to benzodiazepines and increased risk of cleft lip and palate, more recent [...]

By |2019-12-09T22:36:51-04:00December 10th, 2019|Anti-Anxiety Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Interpreting New Data on the Use of Benzodiazepines During Pregnancy

Higher Doses of Topiramate (Topamax) During Pregnancy, Increased Risk of Oral Clefts

Topiramate (TPM, marketed as Topamax) is an antiepileptic drug which is also used for migraine prophylaxis, weight loss, and, less commonly, as a mood stabilizer.  Over the last few years we have seen several studies [...]

By |2018-01-09T11:32:37-04:00January 9th, 2018|Anti-Epileptic Drugs, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Higher Doses of Topiramate (Topamax) During Pregnancy, Increased Risk of Oral Clefts

USPSTF Emphasizes Periconceptual Use of Folic Acid to Prevent Birth Defects

Neural tube defects are among the most common major congenital anomalies in the United States and are associated with significant disability and death.  The risk of neural tube defects can be prevented with daily folic [...]

By |2017-01-13T10:34:56-04:00January 10th, 2017|Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on USPSTF Emphasizes Periconceptual Use of Folic Acid to Prevent Birth Defects
Go to Top